Nikfarjam, M., Shereef, S., Kimchi, E.T., Gusani, N.J., Jiang, Y.X., Avella, D.M., et al. (2009) Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy. Annals of Surgical Oncology, 16, 1860-1867.
http://dx.doi.org/10.1245/s10434-008-0225-3

has been cited by the following article:

• TITLE: Carcinoembryonic Antigen as a Prognostic Factor in Colorectal Cancer with Liver Metastases

  AUTHORS: George E. McNally, David M. Lloyd, Jorge P. Grondona

  KEYWORDS: Carcinoembryonic Antigen (CEA), Colorectal Cancer Survival, Liver Metastasis, Postoperative Mortality

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.12, November 5, 2015

  ABSTRACT: Aim: The objective of this study was to investigate the prognostic value of serum carcinoembryonic antigen (CEA) level in colorectal cancer patients with liver metastases. The serum CEA level was recorded at the point of metastasis diagnosis, differing from the majority of literature looking at preoperative metastasectomy CEA level. Methods: From January 2010 to December 2014, 138 patients with a diagnosis of colorectal cancer and liver metastases were included in the study—population from Buenos Aires, Argentina. Patients with both resectable and unresectable liver metastases were followed up over a 4-year period. Kaplan Meier survival analysis was used to produce survival curves that were compared by log-rank test. Results: The overall survival for all patients studied with a CEA